Division of Pediatric Hematology/Oncology

Clinical Trials

Lymphomas

• AHOD0031: Phase III—Study of dose-intensive, response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed, intermediate risk Hodgkin's disease
  Principal investigator: Cindy Schwartz, MD

• AHOD03P1: Phase III—Treatment of children with newly diagnosed low-stage lymphcyte predominant Hodgkin's disease
  Principal investigator: Cindy Schwartz, MD

• AHOD0031: Phase III—Study for the treatment of children and adolescents with newly diagnosed, low-risk Hodgkin's disease
  Principal investigator: Cindy Schwartz, MD

• ALTE04N1—Health-related outcomes for Hidgkin's diseases survivors
  Principal investigator: Cindy Schwartz, MD

• A5971: Phase III—A randomized study for the treatment of newly diagnosed disseminated lymphoblastic lymphoma or localized lymphoblastic lymphoma
  Principal investigator: Cindy Schwartz, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back